Uchealth Greeley Hospital | |
6767 West 29th Street, Greeley, Colorado 80634 | |
(970) 652-2000 | |
Not Available |
Name | Uchealth Greeley Hospital |
---|---|
Type | Acute Care Hospital |
Location | 6767 West 29th Street, Greeley, Colorado |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 060131 |
NPI Number | 1114611498 |
Organization Name | POUDRE VALLEY HEALTH CARE INC |
Address | 701 Automation Dr, Windsor, CO 80550 |
Hospital Type | General Acute Care Hospital |
Phone Number | 970-232-1750 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
NPI Number | 1780183145 |
Organization Name | UCHEALTH GREELEY HOSPITAL |
Address | 6767 West 29th Street, Greeley, CO 80634 |
Hospital Type | General Acute Care Hospital |
Phone Number | 970-652-2000 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
NPI Number | 1881232692 |
Organization Name | POUDRE VALLEY HEALTH CARE INC |
Address | 701 Automation Dr, Windsor, CO 80550 |
Hospital Type | General Acute Care Hospital |
Phone Number | 720-553-1803 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
NPI Number | 1891332367 |
Organization Name | POUDRE VALLEY HEALTH CARE INC. |
Doing Business As | PVH AMBULANCE NON-EMERGENCY MEDICAL |
Address | 701 Automation Dr, Windsor, CO 80550 |
Hospital Type | General Acute Care Hospital |
Phone Number | 970-237-7910 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
NPI Number | 1952053027 |
Organization Name | POUDRE VALLEY HEALTH CARE INC |
Address | 5881 W 16th St, Greeley, CO 80634 |
Hospital Type | General Acute Care Hospital |
Phone Number | 970-237-7910 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
NPI Number | 1962158857 |
Organization Name | POUDRE VALLEY HEALTH CARE INC |
Doing Business As | POUDRE VALLEY HEALTH SYSTEM |
Address | 5881 W 16th St, Greeley, CO 80634 |
Hospital Type | General Acute Care Hospital |
Phone Number | 720-454-3367 |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers. More than half of human cancers carry defects in the gene for p53, and almost all other cancers, with a normal p53 gene, carry other defects that somehow impair the function of the p53 protein. Inherited mutations in the p53 gene put people at a very high risk of developing a range of cancers.
For years, scientists have been concerned about chemicals in the environment that mimic the estrogens found in the body. In study after study, researchers have found links between these "xenoestrogens" and such problems as decreased sperm viability, ovarian dysfunction, neurodevelopmental deficits and obesity.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
The U.S. Food and Drug Administration is asking commercial food transporters to follow new guidance the agency is issuing today to reduce the chances of physical, chemical, biological and other risks during transportation of foods while the agency reviews current food safety transportation regulations.
› Verified 7 days ago
North Colorado Medical Center Acute Care Hospital Location: 1801 - 16th St, Greeley, Colorado 80631 Phone: (970) 810-4121 | |
Uchealth Greeley Hospital Acute Care Hospital Location: 6767 West 29th Street, Greeley, Colorado 80634 Phone: (970) 652-2000 |